España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
aTyr Pharma
ATYR
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$3.60
0.10
2.99%
Pre-Market: 7:50 PM EDT
Get Report
Comment
aTyr Pharma (ATYR) Forecast
News
Earnings
aTyr Pharma (ATYR) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for aTyr Pharma (NASDAQ:ATYR) Stock
aTyr Pharma Stock (NASDAQ: ATYR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, January 06, 2025
This Toast Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Avi Kapoor
Cantor Fitzgerald Initiates Coverage On aTyr ...
Benzinga Newsdesk
Tuesday, December 10, 2024
HC Wainwright & Co. Reiterates Buy on aTyr Ph...
Benzinga Newsdesk
aTyr Pharma Announces Third DSMB Review For P...
Benzinga Newsdesk
Monday, December 09, 2024
aTyr Pharma To Present Preclinical Research D...
Benzinga Newsdesk
Tuesday, December 03, 2024
HC Wainwright & Co. Reiterates Buy on aTyr Ph...
Benzinga Newsdesk
Friday, November 15, 2024
aTyr Pharma To Present Poster sOn ATYR0101 At...
Benzinga Newsdesk
Thursday, November 07, 2024
aTyr Pharma Q3 2024 GAAP EPS $(0.23) Misses $...
Benzinga Newsdesk
Tuesday, October 29, 2024
HC Wainwright & Co. Reiterates Buy on aTyr Ph...
Benzinga Newsdesk
Tuesday, October 08, 2024
aTyr Pharma's Lead Therapeutic Candidate Efzo...
Benzinga Newsdesk
Friday, October 04, 2024
aTyr Pharma shares are trading higher after W...
Benzinga Newsdesk
Wells Fargo Initiates Coverage On aTyr Pharma...
Benzinga Newsdesk
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Wednesday, October 02, 2024
aTyr Pharma Announces Publication Demonstrati...
Benzinga Newsdesk
Thursday, September 05, 2024
Jefferies Initiates Coverage On aTyr Pharma w...
Benzinga Newsdesk
Thursday, August 15, 2024
HC Wainwright & Co. Reiterates Buy on aTyr Ph...
Benzinga Newsdesk
Wednesday, August 14, 2024
RBC Capital Reiterates Outperform on aTyr Pha...
Benzinga Newsdesk
Tuesday, August 13, 2024
aTyr Pharma Q2 EPS $(0.23) Beats $(0.25) Esti...
Benzinga Newsdesk
Thursday, August 01, 2024
HC Wainwright & Co. Reiterates Buy on aTyr Ph...
Benzinga Newsdesk
Tuesday, July 30, 2024
aTyr Pharma Announces Research Study with Sta...
Benzinga Newsdesk
Thursday, July 25, 2024
Super League Enterprise And 2 Other Stocks Under $2 Insiders Are Buying
Avi Kapoor
Atyr Pharma Director Paul Schimmel Reported P...
Benzinga Newsdesk
Monday, July 22, 2024
HC Wainwright & Co. Reiterates Buy on aTyr Ph...
Benzinga Newsdesk
aTyr Pharma Completes Enrollment Of 268 Patie...
Benzinga Newsdesk
aTyr Pharma Completes Enrollment Of 268 Patie...
Benzinga Newsdesk
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
